Clinical Trial Update: Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing thrice-weekly versus thrice-daily oral ferrous fumarate in adults with iron deficiency anemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferrous Fumarate (ferrous fumarate)

Snippet

Sponsor: Prince of Songkla University | Conditions: Iron Deficiency Anemia | Phase 3 | Status: COMPLETED